I. Valter

发表

A working classification of scleroderma spectrum disorders: a proposal and the results of testing on a sample of patients.

H. Maricq, I. Valter, 2004, Clinical and experimental rheumatology.

An objective method to estimate the severity of Raynaud phenomenon: digital blood pressure response to cooling

H. Maricq, I. Valter, J. G. Maricq, 1998, Vascular medicine.

Effects of Long-Term Denosumab on Bone Histomorphometry and Mineralization in Women With Postmenopausal Osteoporosis

Jacques P. Brown, D. Dempster, I. Valter, 2018, The Journal of clinical endocrinology and metabolism.

Association between cigarette and alcohol consumption and Raynaud's phenomenon.

Y. Palesch, H. Maricq, I. Valter, 1999, Journal of clinical epidemiology.

Effects of Up to 5 Years of Denosumab Treatment on Bone Histology and Histomorphometry: The FREEDOM Study Extension

Jacques P. Brown, I. Reid, P. Miller, 2014, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Evaluation of the efficacy, safety and pharmacokinetic profile of oral recombinant human parathyroid hormone [rhPTH(1-31)NH(2)] in postmenopausal women with osteoporosis.

M. Karsdal, C. Christiansen, P. Alexandersen, 2013, Bone.

Increases in ghrelin and decreases in leptin without altering adiponectin during extreme weight loss in male competitive bodybuilders.

I. Valter, J. Mäestu, J. Jürimäe, 2008, Metabolism: clinical and experimental.

Anabolic and Catabolic Hormones and Energy Balance of the Male Bodybuilders During the Preparation for the Competition

A. Eliakim, I. Valter, J. Mäestu, 2010, Journal of strength and conditioning research.

Prevalence of scleroderma spectrum disorders in the general population of Estonia.

H. Maricq, I. Valter, S. Saretok, 1997, Scandinavian journal of rheumatology.

Prevalence of Raynaud phenomenon in Tartu and Tartumaa, southern Estonia.

H. Maricq, I. Valter, 1997, Scandinavian journal of rheumatology.

Eighteen Months of Treatment With Subcutaneous Abaloparatide Followed by 6 Months of Treatment With Alendronate in Postmenopausal Women With Osteoporosis: Results of the ACTIVExtend Trial

C. Christiansen, D. Black, J. Bilezikian, 2017, Mayo Clinic proceedings.

Vertebral Fractures After Discontinuation of Denosumab: A Post Hoc Analysis of the Randomized Placebo‐Controlled FREEDOM Trial and Its Extension

Jacques P. Brown, S. Cummings, R. Eastell, 2018, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Geographic variation in the prevalence of Raynaud's phenomenon: a 5 region comparison.

M. Weinrich, Y. Palesch, H. Maricq, 1997, The Journal of rheumatology.

A randomized, double-blind, multicenter, placebo-controlled study to evaluate the efficacy and safety of oral salmon calcitonin in the treatment of osteoporosis in postmenopausal women taking calcium and vitamin D.

M. Karsdal, C. Christiansen, P. Alexandersen, 2016, Bone.

Withdrawing Ixekizumab in Patients With Psoriatic Arthritis Who Achieved Minimal Disease Activity: Results From a Randomized, Double‐Blind Withdrawal Study

L. Coates, S. Pillai, P. Mease, 2021, Arthritis & rheumatology.

Effects of denosumab on bone histomorphometry: The FREEDOM and STAND studies

Jacques P. Brown, I. Reid, J. S. San Martin, 2010, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Work disability remains a major problem in rheumatoid arthritis in the 2000s: data from 32 countries in the QUEST-RA Study

A. Woolf, T. Pincus, H. Yamanaka, 2010, Arthritis research & therapy.

Prevalence of Raynaud's phenomenon in 2 ethnic groups in the general population of Estonia.

H. Maricq, I. Valter, Maricq Hr, 1998, The Journal of rheumatology.

Long-term denosumab treatment restores cortical bone loss and reduces fracture risk at the forearm and humerus: analyses from the FREEDOM Extension cross-over group

J. Bilezikian, P. Miller, P. Ebeling, 2019, Osteoporosis International.

Digital vascular responses to cooling in subjects with cold sensitivity, primary Raynaud's phenomenon, or scleroderma spectrum disorders.

M. Weinrich, Y. Palesch, H. Maricq, 1996, Journal of Rheumatology.

Evaluation of treatment efficacy of Raynaud phenomenon by digital blood pressure response to cooling

J. Jennings, H. Maricq, I. Valter, 2000, Vascular medicine.

Effects of Odanacatib on Bone Structure and Quality in Postmenopausal Women With Osteoporosis: 5‐Year Data From the Phase 3 Long‐Term Odanacatib Fracture Trial (LOFT) and its Extension

L. Duong, R. Recker, D. Dempster, 2020, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Anabolic and Catabolic Hormones and Energy Balance of the Male Bodybuilders During the Preparation for the Competition

A. Eliakim, I. Valter, J. Mäestu, 2010, Journal of strength and conditioning research.

Identification of pain categories associated with change in pain in patients receiving placebo: data from two phase 3 randomized clinical trials in symptomatic knee osteoarthritis

M. Karsdal, C. Christiansen, M. Hochberg, 2018, BMC Musculoskeletal Disorders.

Gender, body mass index and rheumatoid arthritis disease activity: results from the QUEST-RA Study.

Ahmad M. Nagm, M. Dougados, A. Woolf, 2010, Clinical and experimental rheumatology.